Related Experiment Video
Updated: Apr 14, 2026
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
PVT1: a rising star among oncogenic long noncoding RNAs
Teresa Colombo1, Lorenzo Farina2, Giuseppe Macino3
1Institute for Computing Applications "Mauro Picone", National Research Council, Via dei Taurini 19, 00185 Rome, Italy.
Abstract:
It is becoming increasingly clear that short and long noncoding RNAs critically participate in the regulation of cell growth, differentiation, and (mis)function. However, while the functional characterization of short non-coding RNAs has been reaching maturity, there is still a paucity of well characterized long noncoding RNAs, even though large studies in recent years are rapidly increasing the number of annotated ones. The long noncoding RNA PVT1 is encoded by a gene that has been long known since it resides in the well-known cancer risk region 8q24. However, a couple of accidental concurrent conditions have slowed down the study of this gene, that is, a preconception on the primacy of the protein-coding over noncoding RNAs and the prevalent interest in its neighbor MYC oncogene. Recent studies have brought PVT1 under the spotlight suggesting interesting models of functioning, such as competing endogenous RNA activity and regulation of protein stability of important oncogenes, primarily of the MYC oncogene. Despite some advancements in modelling the PVT1 role in cancer, there are many questions that remain unanswered concerning the precise molecular mechanisms underlying its functioning.
Insights
Long noncoding RNAs (lncRNAs) like PVT1 are crucial for cell regulation. Research is uncovering PVT1's role in cancer, particularly its interaction with the MYC oncogene, though its mechanisms require further study.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- Short and long noncoding RNAs (lncRNAs) are key regulators of cellular processes.
- Functional characterization of lncRNAs, especially long noncoding RNAs, is still developing.
- The lncRNA PVT1, located in the 8q24 cancer risk region, has been understudied due to a focus on protein-coding genes and the MYC oncogene.
Purpose of the Study:
- To highlight the emerging role of the long noncoding RNA PVT1 in cellular regulation and cancer.
- To discuss recent findings on PVT1's potential mechanisms of action, including competing endogenous RNA activity and regulation of oncogene protein stability.
- To identify knowledge gaps regarding the precise molecular functions of PVT1 in cancer.
Main Methods:
- Literature review of recent studies on PVT1 and noncoding RNAs.
- Analysis of genetic data related to the 8q24 cancer risk region.
- Functional studies investigating PVT1 interactions with MYC and other oncogenes (implied).
Main Results:
- PVT1 is implicated in regulating cell growth, differentiation, and function.
- Emerging evidence suggests PVT1 acts as a competing endogenous RNA.
- PVT1 influences the stability of key oncogenes, notably MYC.
Conclusions:
- PVT1 plays a significant role in cancer, warranting further investigation.
- Understanding PVT1's molecular mechanisms is crucial for advancing cancer research.
- Despite progress, many questions remain about PVT1's precise functions in oncogenesis.
Related Concept Videos
02:39lncRNA - Long Non-coding RNAs
02:39lncRNA - Long Non-coding RNAs
03:18Non-LTR Retrotransposons
01:03Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:03Rous Sarcoma Virus (RSV) and Cancer
01:33Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...